Loading…
Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract
Cyclamen europaeum tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influen...
Saved in:
Published in: | Archives of virology 2019-01, Vol.164 (1), p.243-247 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3 |
---|---|
cites | cdi_FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3 |
container_end_page | 247 |
container_issue | 1 |
container_start_page | 243 |
container_title | Archives of virology |
container_volume | 164 |
creator | Evseenko, Vasily A. Kolosova, Natalia P. Gudymo, Anderi S. Maltsev, Semion V. Bulanovich, Julia A. Goncharova, Nataliya I. Danilchenko, Natalia V. Marchenko, Vasiliy Y. Susloparov, Ivan M. Ryzhikov, Alexander B. |
description | Cyclamen europaeum
tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influenza strain A/California/04/2009 H1N1pdm. Dual intranasal immunization with vaccine compound consisting of 7.5 µg of each hemagglutinin and 500 µg of CTE in 50 µl induced reciprocal GMT on day 21 after immunization 40 (5-640) against H1N1pdm; 43.20 (5-1280) against H3N2; 10.80 (5-80) against influenza B. Animals with HI titers 1/80 against cell-derived antigen were completely protected against challenge with A/California/04/2009 H1N1pdm09. |
doi_str_mv | 10.1007/s00705-018-4023-3 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2109327436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2109327436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3</originalsourceid><addsrcrecordid>eNp1kU2LFDEQhoMo7rj6A7xIwIuX1krSH-mjDKsuLHjRc6hOV48ZutNjPkZnf70ZZlUQvCSk8tRbBQ9jLwW8FQDdu1gOaCoQuqpBqko9YhtRK1nprteP2QYU1JVuQV-xZzHuAUpBNU_ZlQIpm0bKDTve-hTQY8SZu2XJ3t1jcqvn68R32XlCfnA7_sOlbzwFd8SZfOLOT3Mmf48cfXI78hzHfT6WB418OPHtyc64lDLlsB6Q8sJTHihETj_LOJuesycTzpFePNzX7OuHmy_bT9Xd54-32_d3lVWdTJXUCEOnhFBDYxXauhlHNXZj3WvRThKatkEkAVb1U4ugWuwGIW03ku4Ha626Zm8uuYewfs8Uk1lctDTP6GnN0UgBvZJdrdqCvv4H3a85-LLdmdIgtW6bQokLZcMaY6DJHIJbMJyMAHOWYi5STJFizlKMKj2vHpLzsND4p-O3hQLICxDLl99R-Dv6_6m_AAkYmRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2108028865</pqid></control><display><type>article</type><title>Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract</title><source>Springer Nature</source><creator>Evseenko, Vasily A. ; Kolosova, Natalia P. ; Gudymo, Anderi S. ; Maltsev, Semion V. ; Bulanovich, Julia A. ; Goncharova, Nataliya I. ; Danilchenko, Natalia V. ; Marchenko, Vasiliy Y. ; Susloparov, Ivan M. ; Ryzhikov, Alexander B.</creator><creatorcontrib>Evseenko, Vasily A. ; Kolosova, Natalia P. ; Gudymo, Anderi S. ; Maltsev, Semion V. ; Bulanovich, Julia A. ; Goncharova, Nataliya I. ; Danilchenko, Natalia V. ; Marchenko, Vasiliy Y. ; Susloparov, Ivan M. ; Ryzhikov, Alexander B.</creatorcontrib><description>Cyclamen europaeum
tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influenza strain A/California/04/2009 H1N1pdm. Dual intranasal immunization with vaccine compound consisting of 7.5 µg of each hemagglutinin and 500 µg of CTE in 50 µl induced reciprocal GMT on day 21 after immunization 40 (5-640) against H1N1pdm; 43.20 (5-1280) against H3N2; 10.80 (5-80) against influenza B. Animals with HI titers 1/80 against cell-derived antigen were completely protected against challenge with A/California/04/2009 H1N1pdm09.</description><identifier>ISSN: 0304-8608</identifier><identifier>EISSN: 1432-8798</identifier><identifier>DOI: 10.1007/s00705-018-4023-3</identifier><identifier>PMID: 30225522</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Adjuvants, Immunologic ; Administration, Intranasal ; Animals ; Antigens ; Biomedical and Life Sciences ; Biomedicine ; Brief Report ; Cyclamen ; Cyclamen - chemistry ; Guinea Pigs ; Hemagglutinins ; Immunization ; Infectious Diseases ; Influenza ; Influenza B ; Influenza Vaccines - immunology ; Medical Microbiology ; Mucosa ; Orthomyxoviridae Infections - prevention & control ; Plant Extracts - chemistry ; Plant Extracts - pharmacology ; Rhinosinusitis ; Tubers ; Vaccines ; Virology</subject><ispartof>Archives of virology, 2019-01, Vol.164 (1), p.243-247</ispartof><rights>Springer-Verlag GmbH Austria, part of Springer Nature 2018</rights><rights>Archives of Virology is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3</citedby><cites>FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30225522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Evseenko, Vasily A.</creatorcontrib><creatorcontrib>Kolosova, Natalia P.</creatorcontrib><creatorcontrib>Gudymo, Anderi S.</creatorcontrib><creatorcontrib>Maltsev, Semion V.</creatorcontrib><creatorcontrib>Bulanovich, Julia A.</creatorcontrib><creatorcontrib>Goncharova, Nataliya I.</creatorcontrib><creatorcontrib>Danilchenko, Natalia V.</creatorcontrib><creatorcontrib>Marchenko, Vasiliy Y.</creatorcontrib><creatorcontrib>Susloparov, Ivan M.</creatorcontrib><creatorcontrib>Ryzhikov, Alexander B.</creatorcontrib><title>Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract</title><title>Archives of virology</title><addtitle>Arch Virol</addtitle><addtitle>Arch Virol</addtitle><description>Cyclamen europaeum
tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influenza strain A/California/04/2009 H1N1pdm. Dual intranasal immunization with vaccine compound consisting of 7.5 µg of each hemagglutinin and 500 µg of CTE in 50 µl induced reciprocal GMT on day 21 after immunization 40 (5-640) against H1N1pdm; 43.20 (5-1280) against H3N2; 10.80 (5-80) against influenza B. Animals with HI titers 1/80 against cell-derived antigen were completely protected against challenge with A/California/04/2009 H1N1pdm09.</description><subject>Adjuvants, Immunologic</subject><subject>Administration, Intranasal</subject><subject>Animals</subject><subject>Antigens</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brief Report</subject><subject>Cyclamen</subject><subject>Cyclamen - chemistry</subject><subject>Guinea Pigs</subject><subject>Hemagglutinins</subject><subject>Immunization</subject><subject>Infectious Diseases</subject><subject>Influenza</subject><subject>Influenza B</subject><subject>Influenza Vaccines - immunology</subject><subject>Medical Microbiology</subject><subject>Mucosa</subject><subject>Orthomyxoviridae Infections - prevention & control</subject><subject>Plant Extracts - chemistry</subject><subject>Plant Extracts - pharmacology</subject><subject>Rhinosinusitis</subject><subject>Tubers</subject><subject>Vaccines</subject><subject>Virology</subject><issn>0304-8608</issn><issn>1432-8798</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kU2LFDEQhoMo7rj6A7xIwIuX1krSH-mjDKsuLHjRc6hOV48ZutNjPkZnf70ZZlUQvCSk8tRbBQ9jLwW8FQDdu1gOaCoQuqpBqko9YhtRK1nprteP2QYU1JVuQV-xZzHuAUpBNU_ZlQIpm0bKDTve-hTQY8SZu2XJ3t1jcqvn68R32XlCfnA7_sOlbzwFd8SZfOLOT3Mmf48cfXI78hzHfT6WB418OPHtyc64lDLlsB6Q8sJTHihETj_LOJuesycTzpFePNzX7OuHmy_bT9Xd54-32_d3lVWdTJXUCEOnhFBDYxXauhlHNXZj3WvRThKatkEkAVb1U4ugWuwGIW03ku4Ha626Zm8uuYewfs8Uk1lctDTP6GnN0UgBvZJdrdqCvv4H3a85-LLdmdIgtW6bQokLZcMaY6DJHIJbMJyMAHOWYi5STJFizlKMKj2vHpLzsND4p-O3hQLICxDLl99R-Dv6_6m_AAkYmRs</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Evseenko, Vasily A.</creator><creator>Kolosova, Natalia P.</creator><creator>Gudymo, Anderi S.</creator><creator>Maltsev, Semion V.</creator><creator>Bulanovich, Julia A.</creator><creator>Goncharova, Nataliya I.</creator><creator>Danilchenko, Natalia V.</creator><creator>Marchenko, Vasiliy Y.</creator><creator>Susloparov, Ivan M.</creator><creator>Ryzhikov, Alexander B.</creator><general>Springer Vienna</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20190101</creationdate><title>Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract</title><author>Evseenko, Vasily A. ; Kolosova, Natalia P. ; Gudymo, Anderi S. ; Maltsev, Semion V. ; Bulanovich, Julia A. ; Goncharova, Nataliya I. ; Danilchenko, Natalia V. ; Marchenko, Vasiliy Y. ; Susloparov, Ivan M. ; Ryzhikov, Alexander B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adjuvants, Immunologic</topic><topic>Administration, Intranasal</topic><topic>Animals</topic><topic>Antigens</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brief Report</topic><topic>Cyclamen</topic><topic>Cyclamen - chemistry</topic><topic>Guinea Pigs</topic><topic>Hemagglutinins</topic><topic>Immunization</topic><topic>Infectious Diseases</topic><topic>Influenza</topic><topic>Influenza B</topic><topic>Influenza Vaccines - immunology</topic><topic>Medical Microbiology</topic><topic>Mucosa</topic><topic>Orthomyxoviridae Infections - prevention & control</topic><topic>Plant Extracts - chemistry</topic><topic>Plant Extracts - pharmacology</topic><topic>Rhinosinusitis</topic><topic>Tubers</topic><topic>Vaccines</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Evseenko, Vasily A.</creatorcontrib><creatorcontrib>Kolosova, Natalia P.</creatorcontrib><creatorcontrib>Gudymo, Anderi S.</creatorcontrib><creatorcontrib>Maltsev, Semion V.</creatorcontrib><creatorcontrib>Bulanovich, Julia A.</creatorcontrib><creatorcontrib>Goncharova, Nataliya I.</creatorcontrib><creatorcontrib>Danilchenko, Natalia V.</creatorcontrib><creatorcontrib>Marchenko, Vasiliy Y.</creatorcontrib><creatorcontrib>Susloparov, Ivan M.</creatorcontrib><creatorcontrib>Ryzhikov, Alexander B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evseenko, Vasily A.</au><au>Kolosova, Natalia P.</au><au>Gudymo, Anderi S.</au><au>Maltsev, Semion V.</au><au>Bulanovich, Julia A.</au><au>Goncharova, Nataliya I.</au><au>Danilchenko, Natalia V.</au><au>Marchenko, Vasiliy Y.</au><au>Susloparov, Ivan M.</au><au>Ryzhikov, Alexander B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract</atitle><jtitle>Archives of virology</jtitle><stitle>Arch Virol</stitle><addtitle>Arch Virol</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>164</volume><issue>1</issue><spage>243</spage><epage>247</epage><pages>243-247</pages><issn>0304-8608</issn><eissn>1432-8798</eissn><abstract>Cyclamen europaeum
tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influenza strain A/California/04/2009 H1N1pdm. Dual intranasal immunization with vaccine compound consisting of 7.5 µg of each hemagglutinin and 500 µg of CTE in 50 µl induced reciprocal GMT on day 21 after immunization 40 (5-640) against H1N1pdm; 43.20 (5-1280) against H3N2; 10.80 (5-80) against influenza B. Animals with HI titers 1/80 against cell-derived antigen were completely protected against challenge with A/California/04/2009 H1N1pdm09.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>30225522</pmid><doi>10.1007/s00705-018-4023-3</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-8608 |
ispartof | Archives of virology, 2019-01, Vol.164 (1), p.243-247 |
issn | 0304-8608 1432-8798 |
language | eng |
recordid | cdi_proquest_miscellaneous_2109327436 |
source | Springer Nature |
subjects | Adjuvants, Immunologic Administration, Intranasal Animals Antigens Biomedical and Life Sciences Biomedicine Brief Report Cyclamen Cyclamen - chemistry Guinea Pigs Hemagglutinins Immunization Infectious Diseases Influenza Influenza B Influenza Vaccines - immunology Medical Microbiology Mucosa Orthomyxoviridae Infections - prevention & control Plant Extracts - chemistry Plant Extracts - pharmacology Rhinosinusitis Tubers Vaccines Virology |
title | Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T01%3A16%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intranasal%20immunization%20of%20guinea%20pig%20with%20trivalent%20influenza%20antigen%20adjuvanted%20by%20Cyclamen%20europaeum%20tubers%20extract&rft.jtitle=Archives%20of%20virology&rft.au=Evseenko,%20Vasily%20A.&rft.date=2019-01-01&rft.volume=164&rft.issue=1&rft.spage=243&rft.epage=247&rft.pages=243-247&rft.issn=0304-8608&rft.eissn=1432-8798&rft_id=info:doi/10.1007/s00705-018-4023-3&rft_dat=%3Cproquest_cross%3E2109327436%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2108028865&rft_id=info:pmid/30225522&rfr_iscdi=true |